Affiliations: Max-Planck-Institute for Neurological Research, Gleueler Str. 50, 50 931 Köln, Germany, Cologne, Germany | [1] Laboratory of Cell Biology, Istituto Superiore di Sanita, Rome, Italy | [2] CRC Clinical Magnetic Resonance Group, The Institute of Cancer Research and the Royal Marsden NHS Trust, Sutton, Surrey, UK
Abstract: The in vivo relaxation times T1 and T2 were quantitatively determined in rat brain. Animals with implanted experimental brain tumors were investigated for discrimination of pathological regions from normal brain structures based on relaxation time differences. The different cerebral tumors (glioma, schwannoma, neuroblastoma) showed no difference in relaxation times, but all tumors had T1(1301 ± 167 ms) and T2(91 ± 9 ms) times distinctly longer than normal brain (T1: 1057 ± 77 ms; T2: 77 ± 6 ms). T1 can be used for distinction of tumor and edema from normal brain, while T2 is the better parameter for discrimination between tumor and edema. Furthermore, the effect of MRI contrast agents (GdDTPA, MnTPPS, GdTPPS) on the relaxation times of these experimental brain tumors was measured. The enhancement of tumors produced by GdDTPA disappeared within ten minutes after i.p. application. At later times, central cysts and peritumoral edema became the most enhanced structures. The enhancement of tumor following MnTPPS application remained unchanged in T1-weighted images during the whole observation period of four days. A significant reduction of enhancement was not observed during this time. The effect of MnTPPS on T2 was weak. Replacement of manganese with gadolinium as the central ion of the porphyrin TPPS led to a contrast agent with enhancement effects on both, T1- and T2-weighted images.
Keywords: In vivo NMR relaxometry, T1 and T2 relaxation times, Rat brain, Experimental brain tumor, Glioma, Schwannoma, Neuroblastoma
